NCT05092243

Brief Summary

In the current proposal, investigators will investigate three crucial issues of FOG. Firstly, investigators will identify the possible source(s) of FOG in PD and PSP patients during unconstrained walking using a 64-channel ambulatory recorder. The investigators will explore the electric neural sources of FOG and brain connectivity. Secondarily, fMRI during motor imagery will be performed to examine the brain regions involved in the FOG patients. The investigators will merge the electrophysiological and imaging findings to detect the possible neurovascular coupling or uncoupling. Thirdly, electric intervention with transcranial direct current stimulation (tDCS) will be conducted to see whether the FOG situation can be ameliorated in PD and PSP patients. The investigators will deliver a 5-day session of tDCS to the leg motor cortex of the FOG patients to examine whether the intervention will benefit the patients in a double blind randomized design. Six assessments with different combinations of clinical scaling, gait analysis, electrophysiological investigation and fMRI examinations before and after tDCS will be conducted. Besides, there is no long-term cohort investigation of tDCS on neurodegenerative patients with FOG. The investigators will have a 3-year follow-up with a 1-month interval open-label stimulation paradigm for the patients who remained voluntarily after the termination of the initial short-term trials.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 30, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 29, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

October 25, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2022

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2024

Completed
Last Updated

October 25, 2021

Status Verified

October 1, 2021

Enrollment Period

11 months

First QC Date

September 29, 2021

Last Update Submit

October 22, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Electroencephalogram recording before and after the tDCS session

    Gait recording by 64 channels EEG device. Four different frequency bands ( theta, alpha, beta, and gamma) will be investigated. Variables in gait analysis: 1.Gait initiation, 2.Level walking, 3.Gait termination.

    baseline / 2 days, 2 and 4 weeks after the end of the tDCS session

  • Electromyography recording before and after the tDCS session

    The 4 pairs of leg EMG recording during 50 meters walking. The EMG signals will be filtered with a band pass ranging from 0.05 to 70 Hz. Variables in gait analysis: 1.Gait initiation, 2.Level walking, 3.Gait termination.

    baseline / 2 days, 2 and 4 weeks after the end of the tDCS session

  • Functional magnetic resonance images examination before and after the tDCS session

    fMRI scan will be performed on a 3.0T MR imager to detect the brain BOLD signal change in FOG. When fMRI was conducted, four different video tapes will be presented to the subjects:1.normal walking, 2.normal turning, 3.FOG during forward straight walking and 4.FOG during turning.

    baseline / 2 days after the end of the tDCS session

Secondary Outcomes (2)

  • Change in Unified Parkinson's Disease Rating Scale (UPDRS) Part III before and after the tDCS session

    baseline / 2 days, 2 and 4 weeks after the end of the tDCS session

  • Change in Progressive Supranuclear Palsy Rating Scale (PSPRS)

    baseline / 2 days, 2 and 4 weeks after the end of the tDCS session

Other Outcomes (4)

  • Change in New freezing of gait questionnaire (NFOG-Q) before and after the tDCS session

    baseline / 4 weeks after the end of the tDCS session

  • Change in Tinetti's Mobility Index total score before and after the tDCS session

    baseline / 4 weeks after the end of the tDCS session

  • Change inParkinson's Disease Questionnaire 39 (PDQ-39) before and after the tDCS session

    baseline / 4 weeks after the end of the tDCS session

  • +1 more other outcomes

Study Arms (2)

real tDCS

EXPERIMENTAL

In transcranial direct current stimulation, the anodal pad was tapped over the primary motor cortex and the cathode pad was adhered of the contralateral frontal region. A constant current of 2.0 mA will be apply for up to 20 mins.

Device: Transcranial direct current stimulation

sham tDCS

SHAM COMPARATOR

In transcranial direct current stimulation, the sham stimulation will be 30s stimulation with ramp up and ramp off for 10s at 2.0 mA.

Device: Transcranial direct current stimulation

Interventions

A consecutive 5-days course of tDCS will be delivered. In treatment group, true stimulation will be administrated and sham stimulation will be delivered in control group.

real tDCSsham tDCS

Eligibility Criteria

Age30 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients meet the diagnosis of PD or PSP based on the established consensus criteria

You may not qualify if:

  • Impairment of cognition that leads unable to fully cooperate with the oral commands during examinations
  • Functional III or above congestive heart failure, or cancer with distant metastasis
  • Hoehn and Yahr stage 5 in PD or PSP

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital/Neuro Depart

Taichung, 40447, Taiwan

RECRUITING

MeSH Terms

Interventions

Transcranial Direct Current Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Chon-Haw Tsai, PHD

    The chief, Department of Neurology, China Medical University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chon-Haw Tsai, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2021

First Posted

October 25, 2021

Study Start

August 30, 2021

Primary Completion

July 31, 2022

Study Completion

July 31, 2024

Last Updated

October 25, 2021

Record last verified: 2021-10

Locations